GENOME TECHNOLOGY CENTER (GTC) The Genome Technology Center (GTC) shared resource provides centralized, expert genomic services to all Perlmutter Cancer Center (PCC) investigators at NYU Langone Health (NYULH). Under the direction of Dr. Adriana Heguy, a recognized expert in genomic analysis, GTC is a state-of-the-art, high throughput, fast turnaround, fully equipped genomic facility, specializing in both short-read (Illumina) and long-read (PacBio, Oxford Nanopore Technologies) deep sequencing and sample preparation for a variety of applications including RNASeq, ChIPSeq, ATACSeq, bisulfite sequencing, single cell sequencing, chromatin conformation sequencing approaches, and many others. The GTC mission is to foster cross-institutional science by providing highly specialized support in a collaborative environment that results in successful grant applications and publications. GTC provides affordable access to technologically advanced services and instrumentation, and an educational environment for faculty, staff, fellows, and students in the PCC who are interested in learning how these technologies can advance their basic and clinical cancer research.
The Specific Aims of GTC are:
Aim 1) To provide expert genomic services;
Aim 2) To evaluate and implement novel genomic technology and thereby maintain state-of-the-art services;
Aim 3) To facilitate data sharing and storage through high performance computing secure servers;
Aim 4) To assist the CLIA-certified NGS laboratory in technology development and validation;
Aim 5) To educate and inform members of the PCC communities on genomic technologies and their utility for cancer research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016087-40
Application #
10124313
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-12-01
Project End
2024-02-29
Budget Start
2021-03-01
Budget End
2022-02-28
Support Year
40
Fiscal Year
2021
Total Cost
Indirect Cost
Name
New York University
Department
Type
DUNS #
121911077
City
New York
State
NY
Country
United States
Zip Code
10016
Xu, Yang; Taylor, Paul; Andrade, Joshua et al. (2018) Pathologic Oxidation of PTPN12 Underlies ABL1 Phosphorylation in Hereditary Leiomyomatosis and Renal Cell Carcinoma. Cancer Res 78:6539-6548
Gagner, Jean-Pierre; Zagzag, David (2018) Probing Glioblastoma Tissue Heterogeneity with Laser Capture Microdissection. Methods Mol Biol 1741:209-220
Tsay, Jun-Chieh J; Wu, Benjamin G; Badri, Michelle H et al. (2018) Airway Microbiota Is Associated with Upregulation of the PI3K Pathway in Lung Cancer. Am J Respir Crit Care Med 198:1188-1198
Martin, Patricia K; Marchiando, Amanda; Xu, Ruliang et al. (2018) Autophagy proteins suppress protective type I interferon signalling in response to the murine gut microbiota. Nat Microbiol 3:1131-1141
de la Parra, Columba; Ernlund, Amanda; Alard, Amandine et al. (2018) A widespread alternate form of cap-dependent mRNA translation initiation. Nat Commun 9:3068
Coux, Rémi-Xavier; Teixeira, Felipe Karam; Lehmann, Ruth (2018) L(3)mbt and the LINT complex safeguard cellular identity in the Drosophila ovary. Development 145:
Patibandla, Jay R; Fehniger, Julia E; Levine, Douglas A et al. (2018) Small cell cancers of the female genital tract: Molecular and clinical aspects. Gynecol Oncol 149:420-427
Fanok, Melania H; Sun, Amy; Fogli, Laura K et al. (2018) Role of Dysregulated Cytokine Signaling and Bacterial Triggers in the Pathogenesis of Cutaneous T-Cell Lymphoma. J Invest Dermatol 138:1116-1125
Berger, Ashton C; Korkut, Anil; Kanchi, Rupa S et al. (2018) A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers. Cancer Cell 33:690-705.e9
Harper, Lamia; Balasubramanian, Divya; Ohneck, Elizabeth A et al. (2018) Staphylococcus aureus Responds to the Central Metabolite Pyruvate To Regulate Virulence. MBio 9:

Showing the most recent 10 out of 1170 publications